EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lactase Persistence-Associated rs4988235 Polymorphism: A Novel Genetic Link to Cardiovascular Risk via Modulation of ApoB100 and ApoAI

Nihad Kharrat Helu iD, Habib Al Ashkar iD, Nora Kovacs iD, Roza Adany iD, Peter Piko iD

Nutrients · 2025

DOI: 10.3390/nu17172741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Nihad Kharrat Helu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School of Health Sciences, University of Debrecen, 4032 Debrecen, Hungary. Hauptthemen laut MEDLINE: Apolipoprotein B-100, Lactase, Cardiovascular Diseases, Apolipoprotein A-I. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Regional Development Fund, Hungarian Academy of Sciences, Hungarian Research Network - HUN-REN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: As part of the human adaptation to dairy consumption, the presence of the rs4988235-T variant in the MCM6 gene primarily determines lactase persistence in adult European populations, increasing the expression of the lactase-encoding LCT gene. Carriers of the C/C variant are lactose intolerant, while carriers of the T/T or T/C variant have persistent lactase enzyme activity and are able to digest lactose in adulthood. While the association between lactose intolerance and increased cardiovascular risk (CVR) is well-known, the underlying causes have only been partly explored. The present study aimed to investigate the association of rs4988235 polymorphism with significant lipids affecting cardiovascular health and estimated CVR.

Methods

The rs4988235 polymorphism was genotyped in 397 subjects from the general Hungarian population and 368 individuals from the Roma population. To characterize the overall lipid profile, total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), high density lipoprotein cholesterol (HDL-C), apolipoprotein AI (ApoAI), and apolipoprotein B100 (ApoB100) levels were measured, and their ratios (TG/HDL-C, LDL-C/HDL-C, and ApoB100/ApoAI) were calculated. Cardiovascular risk was estimated using the Framingham Risk Score (FRS), Pooled Cohort Equations (PCE), Revised Pooled Cohort Equations (RPCE), and the Systematic Coronary Risk Evaluations (SCORE and SCORE2) algorithms. Adjusted linear and logistic regression analyses were performed, with p < 0.05 considered significant.

Results

The Roma population had a significantly higher prevalence of the C/C genotype than the general population (65.5% vs. 40.3%, respectively). The results of the adjusted linear regression analysis showed a significant association between the C/C genotype and higher LDL-C level (B = 0.126, p = 0.047) and ApoB100 level (B = 0.046, p = 0.013), as well as a higher LDL-C/HDL-C ratio (B = 0.174, p = 0.021) and a higher ApoB100/ApoAI ratio (B = 0.045, p = 0.002), as well as a lower HDL-C level (B = −0.041, p = 0.049). The C/C genotype was also significantly associated with an increased cardiovascular risk (CVR) as estimated by the SCORE (B = 0.235, p = 0.034), SCORE2 (B = 0.414, p = 0.009), PCE (B = 0.536, p = 0.008), and RPCE (B = 0.289, p = 0.045) but not the FRS. After adjusting the statistical model further for ApoAI and ApoB100 levels, the significant correlation with the risk estimation algorithms disappeared (SCORE: p = 0.099; SCORE2: p = 0.283; PCE: p = 0.255; and RPCE: p = 0.370).

Conclusions

Our results suggest that the C/C genotype of rs4988235 is associated with significantly higher ApoB100 and lower ApoAI levels and consequently higher ApoB100/ApoAI ratios, potentially contributing to an increased risk of cardiovascular disease. The results of the statistical analyses suggest that the association between lactose intolerant genotype and cardiovascular risk may be mediated indirectly via modification of the apolipoprotein profile.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein B-100LactaseCardiovascular DiseasesApolipoprotein A-IPolymorphism, Single NucleotideMinichromosome Maintenance Complex Component 6Lactose IntoleranceHumansMaleFemaleMiddle AgedAdultHeart Disease Risk FactorsGenetic Predisposition to DiseaseHungaryAgedGenotypeTriglyceridesRisk Factors

Stichwörter der Autor:innen

ACC/AHA Pooled Cohort EquationsFramingham Risk ScoreHungarianRomaSCORESCORE2SNPcardiovascular risklactase persistencepolymorphism

Substanzen

Apolipoprotein B-100LactaseApolipoprotein A-IMinichromosome Maintenance Complex Component 6MCM6 protein, humanAPOA1 protein, humanTriglycerides

Autor:innen und Institutionen

  • Doctoral School of Health Sciences, University of Debrecen, 4032 Debrecen, Hungary.
  • HUN-REN-UD Public Health Research Group, Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • Department of Public Health and Epidemiology, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
  • National Laboratory for Health Security, Center for Epidemiology and Surveillance, Semmelweis University, 1089 Budapest, Hungary.
  • Institute of Preventive Medicine and Public Health, Semmelweis University, 1089 Budapest, Hungary.

ORCID-Profile: Nihad Kharrat Helu, Habib Al Ashkar, Nora Kovacs, Roza Adany, Peter Piko

Förderung

  • European Regional Development Fund
  • Hungarian Academy of Sciences
  • Hungarian Research Network - HUN-REN
  • National Research, Development, and Innovation Fund of Hungary
  • National Research, Development, and Innovation Office
  • National Research, Development and Innovation Fund.
  • University of Debrecen
  • Tempus Public Foundation and the Hungarian Government

Zitieren

APA

Kharrat Helu, N., Al Ashkar, H., Kovacs, N., Adany, R., & Piko, P. (2025). Lactase Persistence-Associated rs4988235 Polymorphism: A Novel Genetic Link to Cardiovascular Risk via Modulation of ApoB100 and ApoAI. Nutrients. https://doi.org/10.3390/nu17172741

Vancouver

Kharrat Helu N, Al Ashkar H, Kovacs N, Adany R, Piko P. Lactase Persistence-Associated rs4988235 Polymorphism: A Novel Genetic Link to Cardiovascular Risk via Modulation of ApoB100 and ApoAI. Nutrients. 2025. doi:10.3390/nu17172741

BibTeX
@article{KharratHelu2025,
  author = {Kharrat Helu, Nihad and Al Ashkar, Habib and Kovacs, Nora and Adany, Roza and Piko, Peter},
  title = {Lactase Persistence-Associated rs4988235 Polymorphism: A Novel Genetic Link to Cardiovascular Risk via Modulation of ApoB100 and ApoAI},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17172741}
}
Kostenlos starten →